Research / ZS / Fundamental state Inspectable configuration
State dimensions Filing 0001713683-24-000150 General Corporate
Debt relative to revenue 24th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.debt_to_revenue
182.47% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.71% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
52.76% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
26.42% · CORE · VALID
Gross margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
77.47% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-4.88% · CORE · VALID
R&D intensity 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
24.56% · OPTIONAL · VALID
SBC intensity 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
25.03% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Oct 31, 2021 7/8 normalized Level 3 Jan 31, 2022 5/6 normalized Level 3 Apr 30, 2022 7/8 normalized Level 3 Jul 31, 2022 8/8 normalized Level 3 Oct 31, 2022 8/8 normalized Level 3 Jan 31, 2023 8/8 normalized Level 3 Apr 30, 2023 8/8 normalized Level 3 Jul 31, 2023 8/8 normalized Level 3 Oct 31, 2023 8/8 normalized Level 3 Jan 31, 2024 6/6 normalized Level 3 Apr 30, 2024 8/8 normalized Level 3 Jul 31, 2024 8/8 normalized Level 3 Oct 31, 2024 8/8 normalized Level 3 Jan 31, 2025 8/8 normalized Level 3 Apr 30, 2025 8/8 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 52.69%
Current 182.47%
Delta 129.77% Capex Intensity Decreased
Previous 6.67%
Current 2.71%
Delta -3.96% Cash Generation Increased
Previous 35.97%
Current 52.76%
Delta 16.79% Growth Decreased
Previous 34.07%
Current 26.42%
Delta -7.64% Margin Decreased
Previous 77.99%
Current 77.47%
Delta -0.52% Profitability Increased
Previous -5.60%
Current -4.88%
Delta 0.72% R And D Intensity Increased
Previous 23.06%
Current 24.56%
Delta 1.51% Sbc Intensity Increased
Previous 24.34%
Current 25.03%
Delta 0.69% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.